2,3,4,5-tetrahydroxypentanal has been researched along with paclitaxel in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dehghani-Ghobadi, Z; Halvaei, S; Hassani, M; Heidarian, Y; Hossein, G; Hosseini, H; Naderi, N; Sheikh Hassani, S | 1 |
1 other study(ies) available for 2,3,4,5-tetrahydroxypentanal and paclitaxel
Article | Year |
---|---|
Pectasol-C Modified Citrus Pectin targets Galectin-3-induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids.
Topics: Blood Proteins; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystadenocarcinoma, Serous; Drug Synergism; Female; Galectin 3; Galectins; Gene Expression Regulation, Neoplastic; Humans; Integrins; Neoplasm Grading; Ovarian Neoplasms; Paclitaxel; Pectins; Phosphorylation; Signal Transduction; Spheroids, Cellular; STAT3 Transcription Factor; Tumor Cells, Cultured | 2019 |